KLSE (MYR): GENETEC (0104)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
1.88
Today's Change
+0.02 (1.08%)
Day's Change
1.86 - 1.93
Trading Volume
4,367,100
Market Cap
1,457 Million
NOSH
775 Million
Latest Quarter
31-Dec-2023 [#0]
Announcement Date
27-Feb-2024
Next Quarter
31-Mar-2024
Est. Ann. Date
31-May-2024
Est. Ann. Due Date
30-May-2024
QoQ | YoY
26.18% | 82.54%
Revenue | NP to SH
303,436.000 | 76,215.000
RPS | P/RPS
39.15 Cent | 4.80
EPS | P/E | EY
9.83 Cent | 19.12 | 5.23%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.58 | 3.25
QoQ | YoY
16.03% | 8.98%
NP Margin | ROE
25.35% | 17.01%
F.Y. | Ann. Date
31-Dec-2023 | 27-Feb-2024
Latest Audited Result
31-Mar-2023
Announcement Date
31-Jul-2023
Next Audited Result
31-Mar-2024
Est. Ann. Date
31-Jul-2024
Est. Ann. Due Date
27-Sep-2024
Revenue | NP to SH
307,409.000 | 73,400.000
RPS | P/RPS
39.66 Cent | 4.74
EPS | P/E | EY
9.47 Cent | 19.85 | 5.04%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.48 | 3.91
YoY
30.14%
NP Margin | ROE
24.28% | 19.69%
F.Y. | Ann. Date
31-Mar-2023 | 31-May-2023
Revenue | NP to SH
337,570.500 | 88,681.500
RPS | P/RPS
43.55 Cent | 4.32
EPS | P/E | EY
11.44 Cent | 16.43 | 6.09%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
3.12% | 18.13%
NP Margin | ROE
26.26% | 19.79%
F.Y. | Ann. Date
31-Dec-2023 | 27-Feb-2024
Last 10 FY Result | ||||||||||||||
AQR | T4Q | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | 31/03/15 | 31/03/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 337,570 | 303,436 | 307,409 | 223,559 | 97,078 | 80,332 | 97,159 | 101,028 | 70,627 | 129,003 | 145,872 | 116,213 | 11.40% | |
PBT | 95,547 | 82,730 | 80,299 | 62,294 | -4,825 | -1,322 | 4,219 | 5,893 | -3,578 | 8,266 | 3,664 | -830 | - | |
Tax | -6,913 | -5,795 | -5,645 | -4,158 | 439 | 422 | 1,771 | -893 | -58 | -1,472 | 1,306 | 5,741 | - | |
NP | 88,633 | 76,935 | 74,654 | 58,136 | -4,386 | -900 | 5,990 | 5,000 | -3,636 | 6,794 | 4,970 | 4,911 | 35.28% | |
- | ||||||||||||||
NP to SH | 88,681 | 76,215 | 73,400 | 56,400 | -4,246 | -166 | 5,613 | 3,544 | -4,027 | 4,406 | 4,457 | 7,004 | 29.80% | |
- | ||||||||||||||
Tax Rate | 7.24% | 7.00% | 7.03% | 6.67% | - | - | -41.98% | 15.15% | - | 17.81% | -35.64% | - | - | |
Total Cost | 248,937 | 226,501 | 232,755 | 165,423 | 101,464 | 81,232 | 91,169 | 96,028 | 74,263 | 122,209 | 140,902 | 111,302 | 8.53% | |
- | ||||||||||||||
Net Worth | 448,109 | 448,109 | 372,760 | 149,794 | 74,174 | 74,862 | 72,715 | 63,000 | 57,676 | 62,179 | 56,151 | 52,793 | 24.23% |
Equity | ||||||||||||||
AQR | T4Q | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | 31/03/15 | 31/03/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Worth | 448,109 | 448,109 | 372,760 | 149,794 | 74,174 | 74,862 | 72,715 | 63,000 | 57,676 | 62,179 | 56,151 | 52,793 | 24.23% | |
NOSH | 773,830 | 773,830 | 750,157 | 681,961 | 45,639 | 42,361 | 42,265 | 39,220 | 35,168 | 351,206 | 350,944 | 351,959 | 8.76% |
Ratio Analysis | ||||||||||||||
AQR | T4Q | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | 31/03/15 | 31/03/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NP Margin | 26.26% | 25.35% | 24.28% | 26.00% | -4.52% | -1.12% | 6.17% | 4.95% | -5.15% | 5.27% | 3.41% | 4.23% | - | |
ROE | 19.79% | 17.01% | 19.69% | 37.65% | -5.72% | -0.22% | 7.72% | 5.63% | -6.98% | 7.09% | 7.94% | 13.27% | - |
Per Share | ||||||||||||||
AQR | T4Q | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | 31/03/15 | 31/03/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPS | 44.45 | 39.95 | 44.53 | 32.83 | 222.49 | 189.93 | 239.17 | 280.63 | 200.82 | 367.22 | 41.57 | 33.02 | 3.37% | |
EPS | 11.67 | 10.03 | 10.63 | 8.28 | -9.73 | -0.39 | 13.82 | 9.84 | -11.45 | 12.53 | 1.27 | 1.99 | 20.44% | |
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | |
NAPS | 0.59 | 0.59 | 0.54 | 0.22 | 1.70 | 1.77 | 1.79 | 1.75 | 1.64 | 1.77 | 0.16 | 0.15 | 15.28% |
Adjusted Per Share Value based on latest NOSH - 773,830 | ||||||||||||||
AQR | T4Q | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | 31/03/15 | 31/03/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPS | 43.55 | 39.15 | 39.66 | 28.84 | 12.52 | 10.36 | 12.53 | 13.03 | 9.11 | 16.64 | 18.82 | 14.99 | 11.40% | |
EPS | 11.44 | 9.83 | 9.47 | 7.28 | -0.55 | -0.02 | 0.72 | 0.46 | -0.52 | 0.57 | 0.57 | 0.90 | 29.86% | |
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | |
NAPS | 0.5781 | 0.5781 | 0.4809 | 0.1932 | 0.0957 | 0.0966 | 0.0938 | 0.0813 | 0.0744 | 0.0802 | 0.0724 | 0.0681 | 24.24% |
Price Multiplier on Financial Quarter End Date | ||||||||||||||
AQR | T4Q | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | 31/03/15 | 31/03/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | 29/12/23 | 29/12/23 | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 29/03/19 | 30/03/18 | 31/03/17 | 31/03/16 | 31/03/15 | 31/03/14 | - | |
Price | 2.36 | 2.36 | 2.70 | 2.52 | 4.25 | 1.17 | 1.73 | 1.33 | 0.85 | 0.14 | 0.205 | 0.10 | - | |
P/RPS | 5.31 | 5.91 | 6.06 | 7.68 | 1.91 | 0.62 | 0.72 | 0.47 | 0.42 | 0.04 | 0.49 | 0.30 | 39.62% | |
P/EPS | 20.21 | 23.52 | 25.39 | 30.42 | -43.67 | -298.10 | 12.52 | 13.51 | -7.42 | 1.12 | 16.14 | 5.03 | 19.69% | |
EY | 4.95 | 4.25 | 3.94 | 3.29 | -2.29 | -0.34 | 7.99 | 7.40 | -13.47 | 89.59 | 6.20 | 19.90 | -16.45% | |
DY | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | |
P/NAPS | 4.00 | 4.00 | 5.00 | 11.45 | 2.50 | 0.66 | 0.97 | 0.76 | 0.52 | 0.08 | 1.28 | 0.67 | 25.00% |
Price Multiplier on Announcement Date | ||||||||||||||
AQR | T4Q | 31/03/23 | 31/03/22 | 31/03/21 | 31/03/20 | 31/03/19 | 31/03/18 | 31/03/17 | 31/03/16 | 31/03/15 | 31/03/14 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | 27/02/24 | 27/02/24 | 31/05/23 | 26/05/22 | 25/05/21 | 24/06/20 | 28/05/19 | 22/05/18 | 24/05/17 | 24/05/16 | 29/05/15 | 30/05/14 | - | |
Price | 2.19 | 2.19 | 2.40 | 2.44 | 3.79 | 1.40 | 1.39 | 1.40 | 0.865 | 1.22 | 0.165 | 0.095 | - | |
P/RPS | 4.93 | 5.48 | 5.39 | 7.43 | 1.70 | 0.74 | 0.58 | 0.50 | 0.43 | 0.33 | 0.40 | 0.29 | 38.33% | |
P/EPS | 18.76 | 21.82 | 22.57 | 29.46 | -38.95 | -356.70 | 10.06 | 14.22 | -7.55 | 9.73 | 12.99 | 4.77 | 18.83% | |
EY | 5.33 | 4.58 | 4.43 | 3.39 | -2.57 | -0.28 | 9.94 | 7.03 | -13.24 | 10.28 | 7.70 | 20.95 | -15.84% | |
DY | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | |
P/NAPS | 3.71 | 3.71 | 4.44 | 11.09 | 2.23 | 0.79 | 0.78 | 0.80 | 0.53 | 0.69 | 1.03 | 0.63 | 24.21% |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
China Stocks Primed for Bullish Reopen After Upbeat Data
A surge in travel over Lunar New Year bodes well for sentiment
Chinese shares in Hong Kong, US jumped while mainland was shut.
2 months ago
Genetec's quarterly profit soars 82% on higher margin https://klse1.i3investor.com/blogs/genetec_rm400/2024-02-28-story-h-187495562-Genetec_s_quarterly_profit_soars_82_on_higher_margin.jsp
1 month ago
GENETEC Q2 FY24 Briefing https://klse1.i3investor.com/blogs/genetec_rm400/2024-02-29-story-h-187465829-GENETEC_Q2_FY24_Briefing.jsp
1 month ago
CIMB Analysis: Genetec Maintains Growth Trajectory - Strong Buy Recommendation at RM3.60 https://klse.i3investor.com/web/blog/detail/genetec_rm400/2024-02-29-story-h-187464811-CIMB_Analysis_Genetec_Maintains_Growth_Trajectory_Strong_Buy_Recommenda
1 month ago
Genetec main business in EV? US, Europe and their allies announced that they will abandon EV
1 month ago
No standards no principle those countries...they can announce this and later that what...just to suit their benefits.
No doubt EV is the latest and future tech, easy maintenance less spare parts. and they claimed less pollution !!! .....And why they want to use more gasoline...from Russia, Middle East. Yes from US yes but more expensive ??
1 month ago
Malaysia Rises as Crucial Link in Chip Supply Chain
https://www.nytimes.com/2024/03/13/business/malaysia-semiconductors.html
1 month ago
Malaysia gains from US-China trade tensions
https://www.nst.com.my/business/corporate/2024/03/1028636/malaysia-gains-us-china-trade-tensions
1 month ago
February semi sales up 16.3% y-o-y
February semiconductor sales of $46.2 billion were up 16.3% on the February 2023 total of $39.7 billion but 3.1% down on January’s $47.6 billion, says the SIA.
https://www.electronicsweekly.com/news/business/838839-2024-04/
2 weeks ago
TA Securities keeps 'overweight' on tech sector, top picks Inari, Elsoft and MPI..
https://klse.i3investor.com/web/stock/overview/0127
1 week ago
China's EV-powered auto sales rebound, refreshing quarterly high..
https://asia.nikkei.com/Business/Automobiles/China-s-EV-powered-auto-sales-rebound-refreshing-quarterly-high
1 week ago
there is only one way to go up (may fluctuate here and there). Valueinvesting.io As of 2024-04-17, the Intrinsic Value of Genetec Technology Bhd (GENETEC.KL) is 2.52 MYR. This GENETEC.KL valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 1.88 MYR, the upside of Genetec Technology Bhd is 34%.
The range of the Intrinsic Value is 1.65 - 5.44 MYR.
6 days ago
No more selling pressure .. one of the lowest PE and good revenue technology company. Current price consider at the bottom and proof to be at the resistant level.
4 days ago
i think its due to the spill-over effect from ex-director cashing out his stock (latest filing)
1 day ago
Genetec will be on fire guys.. double bottom formation has been completed.. moving up towards TP 2.10
14 hours ago
Hope so ...no more hanky panky ....towards above 2 level
Ron90
Genetec will be on fire guys.. double bottom formation has been completed.. moving up towards TP 2.10
2 minutes ago
14 hours ago
Genetec A baby step
LG to Mass Produce Tesla’s 4680 Batteries This Year https://klse1.i3investor.com/blogs/genetec_rm400/2024-02-16-story-h-188419177-LG_to_Mass_Produce_Tesla_s_4680_Batteries_This_Year.jsp
2 months ago